Printer Friendly

Celesio's CEO to leave Haniel management board.

M2 EUROPHARMA-(C)1999-2009 M2 COMMUNICATIONS

18 December 2009 - German conglomerate Franz Haniel & Cie GmbH said on Friday that Fritz Oesterle would leave its management board at the end of the year.

Oesterle is CEO of drug distributor Celesio AG (ETR: CLS), which is part of Haniel.

Hence, there are no more representatives of Haniel's unit companies on its management board, Haniel's supervisory board head, Franz Haniel, said.

In September, Haniel released Eckhard Cordes from its management board. Cordes is CEO of retailer Metro, also part of the Haniel group. He was replaced by Juergen Kluge who will assume his position on 1 January 2010.

COPYRIGHT 2009 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Dec 18, 2009
Words:105
Previous Article:Swedbank ups target, keeps "strong buy" on Q-Med.
Next Article:Ipsen suffers profit-takings.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters